| [1] |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2021,77(4):e25-e197.
|
| [2] |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632.
|
| [3] |
Généreux P, Schwartz A, Oldemeyer JB, et al. Transcatheter aortic-valve replacement for asymptomatic severe aortic stenosis[J]. N Engl J Med, 2025, 392(3):217-227.
|
| [4] |
Loganath K, Craig NJ, Everett RJ, et al. Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial[J]. JAMA, 2025, 333(3):213-221.
|
| [5] |
Van Mieghem NM, Elmariah S, Spitzer E, et al. Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD[J]. J Am Coll Cardiol, 2025, 85(9):878-890.
|
| [6] |
Hioki H, Yamamoto M, Shirai S, et al. Valve performance between latest-generation balloon-expandable and self-expandable transcatheter heart valves in a small aortic annulus[J]. JACC Cardiovasc Interv, 2024, 17(22):2612-2622.
|
| [7] |
Okuno T, Tomii D, Lanz J, et al. 5-Year outcomes with self-expanding vs balloon-expandable transcatheter aortic valve replacement in patients with small annuli[J]. JACC Cardiovasc Interv, 2023, 16(4):429-440.
|
| [8] |
Amat-Santos IJ, García-Gómez M, Avanzas P, et al. Surgical vs transcatheter treatment in patients with coronary artery disease and severe aortic stenosis[J]. JACC Cardiovasc Interv, 2024, 17(21):2472-2485.
|
| [9] |
Kedhi E, Hermanides RS, Dambrink JE, et al. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial[J]. Lancet, 2025, 404(10471):2593-2602.
|
| [10] |
Lønborg J, Jabbari R, Sabbah M, et al. PCI in patients undergoing transcatheter aortic-valve implantation[J]. N Engl J Med, 2024, 391(23):2189-2200.
|
| [11] |
Narui S. Commissural and coronary alignments in new-generation SEVs [C]. Washington D C:TCT, 2024.
|
| [12] |
Tarantini G. The coronary AccEss after TAVR (CAvEAT) Registry- an international, multicenter prospective registry of coronary access after TAVR [C]. Washington D C: TCT, 2024.
|
| [13] |
Dessalegn N. Commissural misalignment: does it result in early degeneration of transcatheter aortic valve and affect its function? [C]. Washington D C:TCT, 2024.
|
| [14] |
Durand E, Beziau-Gasnier D, Michel M, et al. Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial[J]. Eur Heart J, 2024, 45(11):952-962.
|
| [15] |
Vahl TP, Thourani VH, Makkar RR, et al. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study[J]. Lancet, 2024, 403(10435):1451-1459.
|
| [16] |
Liu X, Zhu Q, Liu Q, et al. Prognostic value of left ventricular systolic function on moderate aortic stenosis: the China-VHD study[J]. Sci Bull (Beijing), 2023, 68(22):2717-2720.
|
| [17] |
Wang MY, Niu GN, Zhou Z, et al. TCT-216 novel artificial intelligence method reveals impact mechanisms from anatomy via prosthesis deformation to hemodynamics in TAVR patients: retrospective study results of 636 paired pre- and post-TAVR CT from China[J]. JAAC, 2024, 84(18 suppl B):B23.
|
| [18] |
Chen SS, Zheng F, Li MF, et al. A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation[J]. Ann Transl Med, 2022, 10(11):643.
|
| [19] |
Yang LF, Chen SS, Zhang XC, et al. Comparisons of noncoronary sinus pivot implantation and conventional method for transcatheter aortic valve replacement with self‐expanding valve in pure aortic regurgitation[J]. Catheter Cardiovasc Interv, 2024, 103(7):1093-1100.
|
| [20] |
中国医师协会心血管内科医师分会结构性心脏病学组，周达新，吴永健. 单纯主动脉瓣反流经股动脉主动脉瓣置换中国专家共识2023[J]. 中国介入心脏病学杂志, 2023, 31(11):801-809.
|
| [21] |
Kong XQ, Zhang J, Gao XF, et al. Single-center experience with self-expanding transcatheter aortic valve system for symptomatic high-risk patients with severe aortic regurgitation: one-year outcomes[J]. Catheter Cardiovasc Interv, 2024, 104(6):1275-1280.
|
| [22] |
Zhang J, Kong XQ, Gao XF, et al. Transfemoral transcatheter aortic valve replacement with VitaFlow(TM) valve for pure native aortic regurgitation in patients with high surgical risk: rationale and design of a prospective, multicenter, and randomized SEASON-AR trial[J]. Am Heart J, 2024, 271:76-83.
|
| [23] |
Chang S, Jiang Z, Liu X, et al. Permanent pacemaker reduction using temporary-permanent pacemaker as a 1-month bridge after transcatheter aortic valve replacement: a prospective, multicentre, single-arm, observational study[J]. EClinicalMedicine, 2024, 72:102603.
|
| [24] |
Xiong TY, Li YM, Yao YJ, et al. Anatomical characteristics of patients with symptomatic severe aortic stenosis in China[J]. Chin Med J (Engl), 2021, 134(22):2738-2740.
|
| [25] |
Li HD, Li WY, Li JL, et al. Long-term durability of transcatheter aortic valve prostheses in patients with bicuspid versus tricuspid aortic valve[J]. J Am Heart Assoc, 2024, 13(21):e035772.
|
| [26] |
Zhuang XD. Nomogram model for predicting the mortality risk in patients with moderate and severe aortic stenosis: development and validation of a novel model in ARISTOTLE study. Reported at ACC2024.
|
| [27] |
Liu Q, Mei J, Zhang H, et al. A novel system for transcatheter aortic valve implantation: first-in-man study[J]. Am J Cardiol, 2024, 211:343-349.
|